Name | Number of supported studies | Average coverage | |
---|---|---|---|
capillary endothelial cell | 3 studies | 21% ± 6% |
Insufficient scRNA-seq data for expression of MYZAP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 8940.00 | 21 / 21 | 85% | 6.28 | 429 / 504 |
prostate | 89% | 2312.09 | 217 / 245 | 95% | 4.94 | 476 / 502 |
pancreas | 89% | 1038.23 | 291 / 328 | 93% | 5.63 | 166 / 178 |
stomach | 95% | 2115.23 | 342 / 359 | 82% | 2.81 | 234 / 286 |
breast | 95% | 2502.67 | 437 / 459 | 73% | 2.62 | 818 / 1118 |
intestine | 73% | 1427.58 | 710 / 966 | 90% | 3.45 | 473 / 527 |
esophagus | 95% | 6407.69 | 1371 / 1445 | 60% | 2.22 | 110 / 183 |
lung | 99% | 3804.04 | 570 / 578 | 51% | 1.31 | 585 / 1155 |
adrenal gland | 100% | 6015.81 | 258 / 258 | 41% | 5.36 | 95 / 230 |
uterus | 86% | 2423.41 | 146 / 170 | 55% | 2.08 | 253 / 459 |
ureter | 0% | 0 | 0 / 0 | 100% | 20.81 | 1 / 1 |
heart | 99% | 29637.82 | 853 / 861 | 0% | 0 | 0 / 0 |
adipose | 96% | 2811.01 | 1155 / 1204 | 0% | 0 | 0 / 0 |
spleen | 83% | 984.36 | 199 / 241 | 0% | 0 | 0 / 0 |
skin | 60% | 744.89 | 1080 / 1809 | 9% | 0.22 | 43 / 472 |
brain | 19% | 332.09 | 491 / 2642 | 33% | 1.20 | 236 / 705 |
thymus | 25% | 209.32 | 162 / 653 | 27% | 0.46 | 163 / 605 |
muscle | 42% | 451.45 | 338 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 36% | 0.86 | 16 / 45 |
lymph node | 0% | 0 | 0 / 0 | 34% | 0.54 | 10 / 29 |
kidney | 16% | 168.30 | 14 / 89 | 16% | 2.92 | 146 / 901 |
ovary | 15% | 143.98 | 27 / 180 | 8% | 0.14 | 35 / 430 |
liver | 0% | 0 | 0 / 226 | 14% | 0.45 | 55 / 406 |
blood vessel | 12% | 216.53 | 161 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
peripheral blood | 1% | 4.33 | 5 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0051685 | Biological process | maintenance of ER location |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0016591 | Cellular component | RNA polymerase II, holoenzyme |
GO_0031674 | Cellular component | I band |
GO_0005622 | Cellular component | intracellular anatomical structure |
GO_0030864 | Cellular component | cortical actin cytoskeleton |
GO_0070161 | Cellular component | anchoring junction |
GO_0005635 | Cellular component | nuclear envelope |
GO_0030018 | Cellular component | Z disc |
GO_0005515 | Molecular function | protein binding |
Gene name | MYZAP |
Protein name | Myocardial zonula adherens protein Myocardial zonula adherens protein (GRINL1A upstream protein) (Gup) |
Synonyms | MYOZAP |
Description | FUNCTION: Plays a role in cellular signaling via Rho-related GTP-binding proteins and subsequent activation of transcription factor SRF (By similarity). Targets TJP1 to cell junctions. In cortical neurons, may play a role in glutaminergic signal transduction through interaction with the NMDA receptor subunit GRIN1 (By similarity). . |
Accessions | ENST00000569089.1 ENST00000461709.1 ENST00000267853.10 [P0CAP1-1] ENST00000380565.8 [P0CAP1-4] H0YCD3 P0CAP1 H3BTD5 |